ABVC BioPharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ABVC BioPharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 84% to $152,430. The net income raised on -$10,515,656 and profit margin reached -6899%. Total operating expenses were $8,066,902.

Profit Margin

ABVC BioPharma, Inc. (NASDAQ:ABVC): Profit margin
2014 0 -70
2015 3.36K -32.28K -960.74%
2016 32 -4.50M -14086871.87%
2017 3.19K -5.04M -157955.91%
2018 6.95K -4.10M -58960.65%
2019 701.71K -3.93M -560.51%
2020 483.04K -10.59M -2193.08%
2021 355.79K -12.03M -3382.79%
2022 969.78K -16.31M -1682.06%
2023 152.43K -10.51M -6898.68%

ABVC Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
152.43K969.78K355.79K483.04K701.71K6.95K3.19K323.36K0
Cost of revenue
302.03K286.41K5.08K18.71K20.13K185.28K2.24K325210
Gross profit
-149.60K683.36K350.71K464.32K681.58K-178.32K94702.83K0
Operating exp.
Research and development
1.06M2.69M1.00M549.65K1.04M669.66K256.68K000
Selling and marketing
00000695.14K1.73M4.49M00
Total operating expenses
8.06M15.79M11.69M8.97M4.14M1.39M1.99M4.49M35.12K70
Operating income
-8.21M-15.11M-11.34M-8.50M-3.45M-1.39M-1.99M-4.49M-32.28K-70
Other income (expenses), net
-2.43M-400.18K134.24K-2.30M-551.50K-2.55M-3.03M14100
Income before tax
-10.65M-15.51M-11.21M-10.81M-4.01M-4.09M-7.03M-4.50M-32.28K-70
Income tax expense
256.00K797.77K825.02K-220.35K-77.04K1.85K-360.39K836-1.89M0
Net income
-10.51M-16.31M-12.03M-10.59M-3.93M-4.10M-5.04M-4.50M-32.28K-70
Earnings per share
Basic EPS
-2.43-5.15-4.8-5.37-2.25-3.53-29.58-4.18-0.37-0.37
Diluted EPS
-2.43-5.15-4.8-5.37-2.25-3.45-29.58-4.18-0.37-0.37
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source